» Articles » PMID: 38296851

Interdigitated Impedimetric-based Maackia Amurensis Lectin Biosensor for Prostate Cancer Biomarker

Overview
Journal Mikrochim Acta
Specialties Biotechnology
Chemistry
Date 2024 Jan 31
PMID 38296851
Authors
Affiliations
Soon will be listed here.
Abstract

Highly specific detection of tumor-associated biomarkers remains a challenge in the diagnosis of prostate cancer. In this research, Maackia amurensis (MAA) was used as a recognition element in the functionalization of an electrochemical impedance-spectroscopy biosensor without a label to identify cancer-associated aberrant glycosylation prostate-specific antigen (PSA). The lectin was immobilized on gold-interdigitated microelectrodes. Furthermore, the biosensor's impedance response was used to assess the establishment of a complex binding between MAA and PSA-containing glycans. With a small sample volume, the functionalized interdigitated impedimetric-based (IIB) biosensor exhibited high sensitivity, rapid response, and repeatability. PSA glycoprotein detection was performed by measuring electron transfer resistance values within a concentration range 0.01-100 ng/mL, with a detection limit of 3.574 pg/mL. In this study, the ability of MAA to preferentially recognize α2,3-linked sialic acid in serum PSA was proven, suggesting a potential platform for the development of lectin-based, miniaturized, and cost effective IIB biosensors for future disease detection.

Citing Articles

Innovations in Biosensor Technologies for Healthcare Diagnostics and Therapeutic Drug Monitoring: Applications, Recent Progress, and Future Research Challenges.

Hemdan M, Ali M, Doghish A, Mageed S, Elazab I, Khalil M Sensors (Basel). 2024; 24(16).

PMID: 39204840 PMC: 11360123. DOI: 10.3390/s24165143.

References
1.
Diaz-Fernandez A, Lorenzo-Gomez R, Miranda-Castro R, de-Los-Santos-Alvarez N, Lobo-Castanon M . Electrochemical aptasensors for cancer diagnosis in biological fluids - A review. Anal Chim Acta. 2020; 1124:1-19. DOI: 10.1016/j.aca.2020.04.022. View

2.
Rawla P . Epidemiology of Prostate Cancer. World J Oncol. 2019; 10(2):63-89. PMC: 6497009. DOI: 10.14740/wjon1191. View

3.
Lilja H, Ulmert D, Vickers A . Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat Rev Cancer. 2008; 8(4):268-78. DOI: 10.1038/nrc2351. View

4.
Gilgunn S, Conroy P, Saldova R, Rudd P, OKennedy R . Aberrant PSA glycosylation--a sweet predictor of prostate cancer. Nat Rev Urol. 2013; 10(2):99-107. DOI: 10.1038/nrurol.2012.258. View

5.
Scott E, Munkley J . Glycans as Biomarkers in Prostate Cancer. Int J Mol Sci. 2019; 20(6). PMC: 6470778. DOI: 10.3390/ijms20061389. View